Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

被引:184
作者
Chen, Xiao
Vodanovic-Jankovic, Sanja
Johnson, Bryon
Keller, Melissa
Komorowski, Richard
Drobyski, William R. [1 ]
机构
[1] Med Coll Wisconsin, Bone Marrow Transplant Program, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
关键词
D O I
10.1182/blood-2007-05-091074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) remains the major complication after allogeneic bone marrow transplantation (BMT). The process whereby acute GVHD mediated by alloreactive donor T cells transitions into chronic GVHD, which is characterized by prominent features of auto-immunity, has long been unresolved. In this study, we demonstrate that GVHD-associated autoimmunity and, by extension, chronic GVHD is attributable to the progressive loss of CD4(+)CD25(+)Foxp3(+) regulatory T cells during the course of acute GVHD. This leads to the expansion of donor-derived CD4(+) T cells with TO and T(H)17 cytokine phenotypes that release proinflarnmatory cytokines and cause autolmmune-mediated pathological damage. These T cells are present early after transplantation, indicating that the pathophysiological events that lead to chronic GVHD are set in motion during the acute phase of GVHD. We conclude that the absence of CD4(+)CD25(+) regulatory T cells coupled with unregulated T(H)1 and T(H)17 cells leads to the development of autoimmunity and that donor-derived TO and T(H)17 cells serve as the nexus between acute and chronic GVHD.
引用
收藏
页码:3804 / 3813
页数:10
相关论文
共 54 条
[1]   Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation [J].
Abu-Ghosh, A ;
Goldman, S ;
Slone, V ;
van de Ven, C ;
Suen, Y ;
Murphy, L ;
Sender, L ;
Cairo, MS .
BONE MARROW TRANSPLANTATION, 1999, 24 (05) :535-544
[2]   FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation [J].
Arimoto, Kazue ;
Kadowaki, Norimitsu ;
Ishikawa, Takayuk ;
Ichinohe, Tatsuo ;
Uchiyama, Takashi .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (02) :154-162
[3]   CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: Protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system [J].
Axtell, Robert C. ;
Xu, Liang ;
Barnum, Scott R. ;
Raman, Chander .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8542-8549
[4]   CYTOKINE DYSREGULATION IN CHRONIC GRAFT-VERSUS-HOST DISEASE [J].
BARAK, V ;
LEVISCHAFFER, F ;
NISMAN, B ;
NAGLER, A .
LEUKEMIA & LYMPHOMA, 1995, 17 (1-2) :169-173
[5]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[6]   CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation [J].
Bharat, A. ;
Fields, R. C. ;
Steward, N. ;
Trulock, E. P. ;
Patterson, G. A. ;
Mohanakumar, T. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (08) :1799-1808
[7]   Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation [J].
Cavet, J ;
Dickinson, AM ;
Norden, J ;
Taylor, PRA ;
Jackson, GH ;
Middleton, PG .
BLOOD, 2001, 98 (05) :1594-1600
[8]   Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease [J].
Cooke, KR ;
Hill, GR ;
Crawford, JM ;
Bungard, D ;
Brinson, YS ;
Delmonte, J ;
Ferrara, JLM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10) :1882-1891
[9]  
DECLERCK Y, 1986, J IMMUNOL, V136, P3549
[10]  
Drobyski WR, 1996, BONE MARROW TRANSPL, V17, P1093